View Item 

Show simple item record

Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis

dc.contributor.authorSchuller, Joseph L.en_US
dc.contributor.authorZipse, Matthewen_US
dc.contributor.authorCrawford, Thomasen_US
dc.contributor.authorBogun, Franken_US
dc.contributor.authorBeshai, Johnen_US
dc.contributor.authorPatel, Amit R.en_US
dc.contributor.authorSweiss, Nadera J.en_US
dc.contributor.authorNguyen, Duy T.en_US
dc.contributor.authorAleong, Ryan G.en_US
dc.contributor.authorVarosy, Paul D.en_US
dc.contributor.authorWeinberger, Howard D.en_US
dc.contributor.authorSauer, William H.en_US
dc.date.accessioned2012-10-02T17:19:52Z
dc.date.available2013-10-18T17:47:30Zen_US
dc.date.issued2012-09en_US
dc.identifier.citationSchuller, Joseph L. ; Zipse, Matthew ; Crawford, Thomas ; Bogun, Frank ; Beshai, John ; Patel, Amit R. ; Sweiss, Nadera J. ; Nguyen, Duy T. ; Aleong, Ryan G. ; Varosy, Paul D. ; Weinberger, Howard D. ; Sauer, William H. (2012). "Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis." Journal of Cardiovascular Electrophysiology 23(9). <http://hdl.handle.net/2027.42/93643>en_US
dc.identifier.issn1045-3873en_US
dc.identifier.issn1540-8167en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/93643
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Incen_US
dc.subject.otherCardiac Sarcoiden_US
dc.subject.otherCardiomyopathyen_US
dc.subject.otherVentricular Tachycardiaen_US
dc.subject.otherHeart Failureen_US
dc.subject.otherImplantable Cardioverter Defibrillatoren_US
dc.titleImplantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPhysiologyen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumSection of Cardiac Electrophysiology, University of Colorado, Denver, Colorado, USA; the Section of Cardiac Electrophysiology, University of Michigan, Ann Arbor, Michigan, USA; and the Section of Cardiac Electrophysiology, University of Chicago, Chicago, Illinois, USAen_US
dc.identifier.pmid22812589en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/93643/1/j.1540-8167.2012.02350.x.pdf
dc.identifier.doi10.1111/j.1540-8167.2012.02350.xen_US
dc.identifier.sourceJournal of Cardiovascular Electrophysiologyen_US
dc.identifier.citedreferenceSilverman KJ, Hutchins GM, Bulkley BH: Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204 ‐ 1211.en_US
dc.identifier.citedreferenceWichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Böcker D: Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single‐center experience of long‐term follow‐up and complications in 60 patients. Circulation 2004; 109: 1503 ‐ 1508.en_US
dc.identifier.citedreferenceReddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME: Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007; 357: 2657 ‐ 2665.en_US
dc.identifier.citedreferenceBardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp‐Channing N, Davidson‐Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH: Amiodarone or an implantable cardioverter‐defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225 ‐ 237.en_US
dc.identifier.citedreferenceWilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter‐Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK: Strategic programming of detection and therapy parameters in implantable cardioverter‐defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008; 52 ( 7 ): 541 ‐ 550.en_US
dc.identifier.citedreferenceEpstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO: ACC/AHA/HRS 2008 Guidelines for Device‐Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350 ‐ e408.en_US
dc.identifier.citedreferenceFerrans VJ, HibbsS RG, Black WC, Walsh JJ, Burch GE: Myocardial degeneration in cardiac sarcoidosis: Histochemical and electron microscopic studies. Am Heart J 1965; 69: 159 ‐ 172.en_US
dc.identifier.citedreferenceRoberts WC, McAllister HA Jr, Ferrans VJ: Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63: 86 ‐ 108.en_US
dc.identifier.citedreferencePerry A, Vuitch F: Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995; 119: 167 ‐ 172.en_US
dc.identifier.citedreferenceChapelon‐Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL, de Gennes C, Papo T, Blétry O, Godeau P, Piette JC: Cardiac sarcoidosis: A retrospective study of 41 cases. Medicine (Baltimore) 2004; 83: 315 ‐ 334.en_US
dc.identifier.citedreferenceCorrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA 3rd, Wichter T, McKenna WJ, Thiene G, Marcus FI: Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010; 122: 1144 ‐ 1152.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1540-8167.2012.02350.x.pdf
Size:
476.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.